about
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeMitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studiesFatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytesRhabdomyolysis-Associated Mutations in Human LPIN1 Lead to Loss of Phosphatidic Acid Phosphohydrolase Activity.High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolismHypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.Dietary fat and antioxidant vitamin intake in patients of neurodegenerative disease in a rural region of Jalisco, MexicoKetogenic diets: from cancer to mitochondrial diseases and beyond.Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.Evaluation of the child with suspected mitochondrial liver diseaseAchieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Dissociating fatty liver and diabetesKetogenic diet and childhood neurological disorders other than epilepsy: an overview.Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.Novel magnetic resonance imaging findings in a patient with short chain acyl CoA dehydrogenase deficiency.Infant with hepatomegaly and hypoglycemia: A setting for fatty acid oxidation defects.Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.
P2860
Q26765455-B66AC03A-91BB-4B7B-9BEA-AD5A6D04035BQ28085600-EE1C42EE-5BD0-4177-8051-D061718C4B2AQ28566783-19949BAC-812F-4DBF-9FA6-0FDA3C8C57A2Q30384327-2A7EFBD6-538C-4169-8B3C-AB17C5AB97BEQ33727858-F9A03451-8CC0-4D5E-9CB3-4D96E2C96736Q33846446-AFDAF19B-A0E0-47CE-A724-7AE90A618039Q34230920-B2A4538A-46BC-43C4-B264-9AEEB08848ABQ34509699-ACA38E6F-0B97-442B-A47D-64CCDDFD6DB1Q35838049-10D96E63-725A-42D8-8982-DBA089F7265FQ36215331-6392C960-457D-4855-B423-E2A17C917F36Q37260504-E61ACC8F-BADA-4758-862C-4F5C2C52A7F4Q37333950-6C9B3F5F-10D0-43C1-8BBB-8015473A2123Q37375389-302A14C3-D51C-4BD3-8A73-A1CEC03A070EQ38050214-93A900C0-1B71-4CC0-AEDE-16880546EFCFQ39007510-0B132076-CA02-4D1A-97BF-8881DC420057Q39314157-04D99115-1068-41C7-AD86-F0A32DA8DE76Q47758040-65174B31-5749-4313-A2CE-8C470E790184Q48126558-E1C6B941-0233-4132-9647-77F351573EABQ53836718-AE73F3AD-6A28-4A9C-9085-7AF1FFB5A3B0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of fatty acid oxidation disorders.
@en
Pathophysiology of fatty acid oxidation disorders.
@nl
type
label
Pathophysiology of fatty acid oxidation disorders.
@en
Pathophysiology of fatty acid oxidation disorders.
@nl
prefLabel
Pathophysiology of fatty acid oxidation disorders.
@en
Pathophysiology of fatty acid oxidation disorders.
@nl
P1476
Pathophysiology of fatty acid oxidation disorders.
@en
P2093
M J Bennett
P2860
P2888
P304
P356
10.1007/S10545-010-9170-Y
P577
2009-10-10T00:00:00Z